Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Zai Lab Limited

Market Cap 198.19Cr 171.99Cr 158.54Cr 148.55Cr 277.56Cr 19TCr 283.34Cr 1.89TCr 732.21Cr 9.15TCr 744.02Cr 727.99Cr 32TCr P/E Ratio 2026 *
-7.97x
P/E Ratio 2027 * -9.46x
Enterprise Value 153.88Cr 133.54Cr 123.09Cr 115.34Cr 215.5Cr 15TCr 219.99Cr 1.47TCr 568.5Cr 7.1TCr 577.67Cr 565.22Cr 25TCr EV / Sales 2026 *
3.43x
EV / Sales 2027 * 2.68x
Free-Float
95.17%
Yield 2026 *
-
Yield 2027 * -
1 day+2.20%
1 week+1.73%
Current month-0.28%
1 month-9.95%
3 months-7.50%
6 months-1.01%
1 week 16.26
Extreme 16.26
17.91
1 month 16.26
Extreme 16.26
21.33
Current year 15.96
Extreme 15.96
25.28
1 year 15.96
Extreme 15.96
42
3 years 13.48
Extreme 13.48
44.34
5 years 13.48
Extreme 13.48
178.91
10 years 13.48
Extreme 13.48
193.54
Manager TitleAgeSince
Chief Executive Officer 60 01/04/2014
Director of Finance/CFO 58 07/07/2023
President 62 01/12/2022
Director TitleAgeSince
Chairman 60 01/04/2014
Director/Board Member 82 01/01/2017
Director/Board Member 74 01/01/2017
Date Insider Type Main position Quantity % Market Cap.
27/05Don

Chief Executive Officer

-87,843 0.0077%
27/05Other

Chief Executive Officer

-8,78,430 0.0775%
26/05Other

Chief Executive Officer

-1,98,570 0.0175%
Change 5-day change 1-year change 3-year change Capi.($)
+2.20%+1.73%-57.39%-37.36% 193.92Cr
+1.63%-2.74%+17.91%-18.09% 6.12TCr
+2.50%+4.43%+64.44%+216.37% 5.82TCr
-0.92%+28.60%+28.60%+28.60% 3.95TCr
+1.31%+17.46%-54.84%-64.75% 3.51TCr
+2.94%+1.79%+50.28%-35.26% 2.87TCr
+2.32%+6.51%+56.62%+76.65% 2.11TCr
+7.94%-3.78%+78.88%-59.73% 1.82TCr
-1.88%-5.07%-10.05%+93.76% 1.65TCr
+0.78%+0.78%+49.83%+98.01% 1.59TCr
Average +1.89%+1.18%+22.43%+29.82% 2.96TCr
Weighted average by Cap. +1.76%+1.43%+29.16%+43.46%

Financials

2026 *2027 *
Net sales 45Cr 39Cr 36Cr 34Cr 63Cr 4.3TCr 64Cr 428.15Cr 165.77Cr 2.07TCr 168.44Cr 164.81Cr 7.2TCr 60Cr 52Cr 48Cr 45Cr 83Cr 5.7TCr 85Cr 568.31Cr 220.03Cr 2.75TCr 223.58Cr 218.76Cr 9.56TCr
Net income -24Cr -21Cr -19Cr -18Cr -34Cr -2.31TCr -34Cr -229.87Cr -89Cr -1.11TCr -90Cr -88Cr -3.87TCr -16Cr -14Cr -13Cr -12Cr -22Cr -1.5TCr -22Cr -149.31Cr -58Cr -722.19Cr -59Cr -57Cr -2.51TCr
Net Debt -44Cr -38Cr -35Cr -33Cr -62Cr -4.24TCr -63Cr -422.84Cr -163.71Cr -2.05TCr -166.35Cr -162.77Cr -7.11TCr -39Cr -34Cr -31Cr -29Cr -54Cr -3.71TCr -55Cr -369.46Cr -143.04Cr -1.79TCr -145.35Cr -142.22Cr -6.21TCr
Logo Zai Lab Limited
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.
Employees
1,784
Date Price Change Volume
11/26/11 17.64 $ +2.20% 10,05,002
10/26/10 17.26 $ +3.66% 11,71,343
09/26/09 16.65 $ +1.03% 13,80,829
08/26/08 16.48 $ -0.84% 10,84,399
05/26/05 16.62 $ -4.15% 16,94,996
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
17.64USD
Average target price
33.30USD
Spread / Average Target
+88.79%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ZLAB Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!